-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Kiromic Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2020 to Q1 2024.
- Kiromic Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 1.3M shares, a 49.5% increase year-over-year.
- Kiromic Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.1M shares, a 102% increase from 2022.
- Kiromic Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 544K shares, a 43.1% increase from 2021.
- Kiromic Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 381K shares, a 91.6% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)